- Filed
- Feb 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 13, 2024 | 7.42M sh |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $390.44K |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $889.67K |
| Cash And Equivalents | Q2 2024 · Dec 31, 2022 | $313.5K |
| Cash And Equivalents | Q2 2024 · Jun 30, 2022 | $593.87K |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $2.54M |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $2.85M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $2.87M |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $3.37M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $4.17M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $4.64M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $4.71M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $5.31M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 7.42M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 7.42M sh |
| Capex | Q2 2024 · Dec 31, 2022 | $0 |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | −$270.6K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $1.15M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $1.16M |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | $1.48M |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$0.05 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.00 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | −$0.05 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $1.06M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $2.17M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $191.33K |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $455.57K |
| Net Income | Q2 2024 · Dec 31, 2022 | −$6.04K |
| Net Income | Q2 2024 · Dec 31, 2022 | −$326.77K |
| Net Income | Q2 2024 · Sep 30, 2022 | −$320.72K |
| Operating Income | Q2 2024 · Dec 31, 2022 | $3 |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$315.89K |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $1.75M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $3.3M |